Advisor Group Holdings, Inc. Bio N Tech Se Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Bio N Tech Se stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 2,260 shares of BNTX stock, worth $275,991. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,260

Previous 2,439 7.34%

Holding current value

$275,991

Previous $195,000 37.44%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$78.36 - $124.66 $14,026 - $22,314	-179 Reduced 7.34%	2,260 $268,000
Q2 2024 Aug 13, 2024	SELL	$80.36 - $102.87 $267,839 - $342,865	-3,333 Reduced 57.74%	2,439 $195,000
Q1 2024 May 10, 2024	SELL	$88.96 - $112.35 $283,426 - $357,947	-3,186 Reduced 35.57%	5,772 $532,000
Q4 2023 Feb 12, 2024	BUY	$90.91 - $112.75 $68,455 - $84,900	753 Added 9.18%	8,958 $945,000
Q3 2023 Nov 13, 2023	BUY	$98.5 - $125.08 $126,080 - $160,102	1,280 Added 18.48%	8,205 $891,000
Q2 2023 Aug 10, 2023	SELL	$102.58 - $129.66 $92,937 - $117,471	-906 Reduced 11.57%	6,925 $747,000
Q1 2023 May 12, 2023	SELL	$122.57 - $153.67 $84,083 - $105,417	-686 Reduced 8.05%	7,831 $975,000
Q4 2022 Feb 10, 2023	SELL	$118.43 - $186.05 $78,874 - $123,909	-666 Reduced 7.25%	8,517 $1.28 Million
Q3 2022 Nov 14, 2022	SELL	$127.65 - $183.11 $79,781 - $114,443	-625 Reduced 6.37%	9,183 $1.24 Million
Q2 2022 Aug 10, 2022	SELL	$123.25 - $186.24 $14,050 - $21,231	-114 Reduced 1.15%	9,808 $1.46 Million
Q1 2022 May 04, 2022	SELL	$126.25 - $231.85 $3.5 Million - $6.43 Million	-27,733 Reduced 73.65%	9,922 $1.83 Million
Q3 2021 Nov 05, 2021	SELL	$205.93 - $447.23 $226,934 - $492,847	-1,102 Reduced 2.84%	37,655 $10.3 Million
Q2 2021 Aug 02, 2021	BUY	$113.32 - $241.49 $2.51 Million - $5.35 Million	22,134 Added 133.15%	38,757 $8.68 Million
Q1 2021 May 13, 2021	BUY	$85.73 - $119.5 $428,564 - $597,380	4,999 Added 43.01%	16,623 $1.81 Million
Q4 2020 Feb 10, 2021	BUY	$72.71 - $129.54 $361,223 - $643,554	4,968 Added 74.64%	11,624 $947,000
Q3 2020 Nov 12, 2020	BUY	$57.81 - $104.17 $344,085 - $620,019	5,952 Added 845.45%	6,656 $461,000
Q2 2020 Aug 14, 2020	BUY	$38.58 - $66.74 $27,160 - $46,984	704 New	704 $47,000

Others Institutions Holding BNTX

# of Institutions

358

Shares Held

38.4M

Call Options Held

2.45M

Put Options Held

2.29M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $29.6B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Bio N Tech Se Transaction History